Subscribe to RSS
DOI: 10.1055/s-0029-1185742
© Georg Thieme Verlag KG Stuttgart · New York
Reduction of β-Asarone in Acori Rhizoma by Decoction
Publication History
received Nov. 26, 2008
revised April 9, 2009
accepted April 26, 2009
Publication Date:
08 June 2009 (online)

Abstract
β-Asarone, the major constituent of the essential oil from the traditional Chinese herbal drug “Acori rhizoma” is regarded as carcinogenic in rodents and potentially genotoxic. Thus, the limit for the ingestion of this constituent from herbal medicinal products has been set at 0.115 mg β-asarone/person/day. The present study demonstrates that a decoction procedure, traditionally used for Chinese herbal preparations and intended as the standard procedure in Ph. Eur., was able to significantly reduce the amount of β-asarone. HPLC analysis indicated that the content of β-asarone in dried herbal drug ranged from 15.22 to 25.34 mg/g. During a 1-hour decoction, the amount of β-asarone decreased more than 85 % and the aqueous extract contained the equivalent of only 0.46–2.19 mg β-asarone per gram of herbal drug. If this aqueous extract was heated for a further 2 hours, the final content of β-asarone was reduced to the equivalent of no more than 0.005 mg per gram of herbal drug. This low level of β-asarone should be acceptable for therapeutic use. It was noted that decoction of Acori rhizoma in the presence of other herbal substances impaired, to some extent, the reduction in β-asarone.
Key words
Acori rhizoma - Acorus tatarinowii Schott - Araceae - β‐asarone - traditional Chinese medicine - HPLC analysis
References
- 1 Mehrotra S, Mishra K P, Maurya R, Srimal R C, Yadav V S, Pandey R, Singh V K. Anticellular and immunosuppressive properties of ethanolic extract of Acorus calamus rhizome. Int Immunopharmacol. 2003; 3 53-61
- 2 Parab R S, Mengi S A. Hypolipidemic activity of Acorus calamus L. in rats. Fitoterapia. 2002; 73 451-455
- 3 Chinese Pharmacopoeia Commission .Pharmacopoeia of the People's Republic of China, Volume I. Beijng; People's Medical Publishing Press 2005: 247-248
- 4 Zhu Y P. Chinese materia medica: chemistry, pharmacology and application. Amsterdam; Harwood Academic Publishers 1998: 541-543
- 5 Liu X P, Wang Y L, Zhang H X, Pan Y. The effects of Acorus tatarinowii Schott decoction on withdrawal syndromes in morphine dependent rats. Chin J Pain Med. 2007; 13 164-165, 170
- 6 Nishiyama N, Zhou Y, Saito H. Ameliorative effects of chronic treatment using DX-9386, a traditional Chinese prescription on learning performance and lipid peroxide content in senescence accelerated mouse. Biol Pharm Bull. 1994; 17 1481-1484
- 7 Nishiyama N, Zhou Y, Saito H. Beneficial effects of DX-9386, a traditional Chinese prescription, on memory disorder produced by lesioning the amygdala in mice. Biol Pharm Bull. 1994; 17 1679-1681
- 8 Zhang Y, Takashina K, Saito H, Nishiyama N. Anti-aging effect of DX-9386 in senescence-accelerated mouse. Biol Pharm Bull. 1994; 17 866-868
- 9 Oh M H, Houghton P J, Whang W K, Cho J H. Screening of Korean herbal medicines used to improve cognitive function for anti-cholinesterase activity. Phytomedicine. 2004; 11 544-548
- 10 Jagmohan S B, Vikram D, Jatinder S, Sukhdev S K, Kamaljeet K N, Javed N A. Novel lectins from rhizomes of two Acorus species with mitogenic activity and inhibitory potential towards murine cancer cell lines. Int Immunopharmacol. 2005; 5 1470-1478
- 11 Yang L B, Li S L, Wang S Q, Zhang S Q. Effect of Acorus gramineus and its active component α-asarone on N-methyl-D-asperate receptor 1 of hippocamp neurons in epileptic young rats. Chin Tradit Herb Drugs. 2007; 38 1670-1673
- 12 Cho J, Joo N E, Kong J Y, Jeong D Y, Lee K D, Kang B S. Inhibition of excitotoxic neuronal death by methanol extract of Acori graminei rhizoma in cultured rat cortical neurons. J Ethnopharmacol. 2000; 73 31-37
- 13 Koo B S, Park K S, Ha J H, Park J H, Lim J C, Lee D U. Inhibitory effects of the fragrance inhalation of essential oil from Acorus gramineus on central nervous system. Biol Pharm Bull. 2003; 26 978-982
- 14 Oprean R, Tamas M, Roman L. Comparison of GC–MS and TLC techniques for asarone isomers determination. J Pharm Biomed Anal. 1998; 18 227-234
- 15 Hasheminejad G, Caldwell J. Genotoxity of the alkenylbenzenes α-asarone and β-asarone, myristicin and elemicin as determined by the UDS assay in cultured rat hepatocytes. Food Chem Toxicol. 1994; 32 223-231
- 16 Scientific Committee on Food, European Commission .Opinion of the Scientific Committee on Food on the presence of β-asarone in flavorings and other food ingredients with flavoring properties (SCF/CS/FLAV/FLAVOUR/9 ADD1 Final). 2002 Available at ec.europa.eu/food/fs/sc/scf/out111_en.pdf. Accessed August 21, 2008
-
17 European Medicines Agency .Public statement on the use of herbal medicinal products containing asarone (EMEA/HMPC/139215/2005). Available at www.emea.europa.eu/pdfs/human/hmpc/13921505en.pdf. Accessed August 21, 2008
Prof. Dr. Beat Meier
Institute of Biotechnology
Zurich University of Applied Sciences
Grüental
Postfach
CH-8820 Wädenswil
Switzerland
Phone: + 41 5 89 34 58 06
Fax: + 41 5 89 34 59 95
Email: beat.meier@zhaw.ch